Cybulsky A V, Matni A, Hollomby D J
Nephron. 1985;41(1):57-61. doi: 10.1159/000183547.
The effects of high sodium 144 mmol/l (mEq/l) dialysate were studied in normotensive, hypertensive and anephric chronic hemodialysis patients. Comparisons of blood pressures, weights and side effects associated with the hemodialysis procedure were made between two 6-month periods using dialysate sodium concentration of 133 mmol/l (mEq/l), followed by a high dialysate sodium of 144 mmol/l (mEq/l), each patient acting as his own control. No difference was found in the frequency of cramps or 'disequilibrium' side effects (nausea, vomiting, headache, restlessness). High sodium dialysate is beneficial for normotensive and anephric patients in reducing dialysis-induced hypotension and was not associated with any deleterious effects on long-term blood pressure control. In hypertensive patients, the benefit is less clear, and hypertension may increase.
研究了高钠（144毫摩尔/升（毫当量/升））透析液对血压正常、高血压和无肾的慢性血液透析患者的影响。在两个6个月期间，分别使用133毫摩尔/升（毫当量/升）的透析液钠浓度，随后使用144毫摩尔/升（毫当量/升）的高透析液钠浓度，以每位患者自身作为对照，比较了与血液透析过程相关的血压、体重和副作用。在痉挛或“失衡”副作用（恶心、呕吐、头痛、烦躁）的发生率上未发现差异。高钠透析液有利于血压正常和无肾患者减少透析引起的低血压，并且与长期血压控制的任何有害影响无关。在高血压患者中，益处不太明显，并且血压可能会升高。
